Sign In
Buy RBGPF
$66.00
+0 (+0%)
At Close: Jul 31, 2026
Reckitt Benckiser thanks strong condom sales for protecting softer sales in US and EU
02:52am, Wednesday, 23'rd Apr 2025
Strong sales of condoms and growth in emerging markets enabled Reckitt Benckiser Group PLC (LSE:RKT) to offset weaker trading in Europe, North America and the Home division in the first quarter of
Trump Tariffs Drama: Staples Companies To The Rescue?
04:41pm, Thursday, 03'rd Apr 2025
President Trump's “Liberation Day” announcement rattled the market, leaving only few stocks in the green. The likelihood of a stagflationary environment and recession has increased significantly.
The Most 'Unethical' Dividend Portfolio Ever: Paying Your Bills With The Vices Of Humankind
07:09pm, Monday, 24'th Mar 2025
Human vices like alcohol, tobacco, and sex persist; companies in these industries remain profitable and offer attractive dividends despite societal disapproval. The tobacco industry is in slow decline
Reckitt Benckiser Group plc (RBGPF) Q4 2024 Earnings Call Transcript
10:15am, Friday, 07'th Mar 2025
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q4 2024 Earnings Conference Call March 6, 2025 3:30 AM ET Company Participants Nick Ashworth - Head of Investor Relations Kris Licht - Chief Executive Officer
Reckitt Benckiser ups dividend as profit slips on reshuffle
02:46am, Thursday, 06'th Mar 2025
Reckitt Benckiser Group PLC has upped its dividend after a drop in profit last year as efforts continued to revamp the consumer goods business. Operating profit fell 4.2% to £2.43 billion in the year
Reckitt Benckiser Group: New Bull Run Initiated
09:32am, Wednesday, 26'th Feb 2025
Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high-gro
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reckitt Benckiser Group plc - RBGLY
10:00am, Saturday, 15'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or the "Company") (OTCMKTS:RBGLY). Such inve
NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Reckitt Benckiser Group plc ("Reckitt" or "the
NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Reckitt Benckiser Group plc ("Reckitt" or "the
RBGLY Investors Have Opportunity to Join Reckitt Benckiser Group plc Securities Fraud Investigation with the Schall Law Firm
02:58pm, Thursday, 30'th Jan 2025
LOS ANGELES--(BUSINESS WIRE)--RBGLY Investors Have Opportunity to Join Reckitt Benckiser Group plc Securities Fraud Investigation with the Schall Law Firm.
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
10:00am, Monday, 30'th Dec 2024
I review here the stocks of six quality companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. Dividend growth investing is
Reckitt Benckiser: Still Cheap On Nutrition Woes
05:18pm, Monday, 23'rd Dec 2024
Reckitt Benckiser shareholders have had a tough year, with the stock underperforming global staples by around 17 points since my last article in January. Uncertainty surrounding the cost of litigation
Reckitt Benckiser adds tier-one execs to board
04:55am, Wednesday, 27'th Nov 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) bolstered its boardroom, adding more c-suite expertise in non-executive positions. Bacardi chief executive Mahesh Madhavan is taking a seat as a non-exec
Reckitt Benckiser got 'best-case' outcome in latest US infant formula trial, broker suggest
08:26am, Friday, 01'st Nov 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) got the 'best case scenario' result in the Whitfield trial in Missouri, say analysts at Barclays, as all the infant formula NEC liability claims were d
Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling
05:37am, Friday, 01'st Nov 2024
A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC
